References:
  1. Scarpignato, C., Bjarnason, I. Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical Condition. Current Gastroenterology Reports. 2019; 21: 55
  2. Marietta et al. Immunopathogenesis of Olmesartan-Associated Enteropathy. Aliment Pharmacology Therapy. 2015;42:1303-1314
  3. Hammoudi, N., Dior, M., Giraud, V., Coffin, B. Olmesartan-induced Enteropathy, associated with cutaneous lesions. Clinical Case Reports. 2016;4:379-382
  4. Bolognia, J., Jorizzo, J., Schaffer, J., Dermatology fourth edition. Elsevier Saunders, 2012.
  5. Reunala T, Salmi TT, Hervonen K, Kaukinen K, Collin P. Dermatitis Herpetiformis: A Common Extraintestinal Manifestation of Coeliac Disease. Nutrients. 2018;10:602.
  6. Melis, C., Struyve, M., Steelandt, T., Neuville, B., Deraedt, K. Sprue-like enteropathy, do not forget olmesartan! Digestive and Liver Disease. 2018;50:621-624
The authors confirm contribution to the paper as follows:
Study conception and design: Francis Essien D.O., Wassem Juakiem M.D., Jared Roberts M.D.
Data collection: Francis Essien D.O.
Analysis and interpretation of results: Francis Essien D.O., Jared Roberts M.D.
Draft manuscript preparation: Francis Essien D.O., Joshua Tate M.D.
Figure 1. A. 9 cm x 9 cm scar with multiple ulcerated lesions on the anterior supra-umbilical region)
B. Histopathology: ulceration with extensive dermal fibrosis, chronic inflammation, numerous eosinophils and granulation tissue
C. 1 month following losartan discontinuation.